Actio Biosciences
San Diego, California, United States · Biotechnology, Health Care, Therapeutics · 41 employees
Actio Biosciences is leveraging advances in precision medicine to develop new therapeutics that target shared genetics in rare and common diseases—bringing meaningful medicines from one to many. Applying its expertise in genetics, drug discovery and data sciences, Actio seeks to identify programs targeting the underlying cause of disease where biological risk can be minimized to streamline the dru
Funding history
- Series series b — $66.0M — Jun 2025
Recent signals
- Jun 18, 2025: Raised $66.0M in Series series b
- Jan 08, 2025: Actio Biosciences Appoints Cayce Denton as Chief Financial Officer
- Aug 20, 2024: Actio Biosciences Appoints Dimitrios Arkilo, M.D., as Chief Medical Officer
See plans & pricing → Track Actio Biosciences’s funding, hiring, and signals — with verified contacts — on Fundz.